Last $122.01 USD
Change Today +0.90 / 0.74%
Volume 3.5M
AMGN On Other Exchanges
Symbol
Exchange
Hong Kong
Mexico
NASDAQ GS
Sao Paulo
Frankfurt
As of 4:30 PM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert A. Bradway

Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee, Amgen Inc.
AgeTotal Calculated CompensationThis person is connected to 23 board members in 2 different organizations across 3 different industries.

See Board Relationships
51$13,649,807
As of Fiscal Year 2013

Background*

Mr. Robert A. Bradway, also known as Bob, has been the Chief Executive Officer and President of Amgen, Inc. since May 23, 2012 and May 2010 respectively. Mr. Bradway is responsible for the Amgen's global commercial operations, manufacturing operations, information technology, global government affairs and worldwide compliance and business ethics organizations. He served as the Chief Operating Officer of Amgen from May 2010 to May 23, 2012. He served as the Chief Financial ...

Read Full Background

Corporate Headquarters*

One Amgen Center Drive
Thousand Oaks, California 91320

United States

Phone: 805-447-1000
Fax: 805-447-1010

Board Members Memberships*

2011-Present
Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
2011-Present
Independent Director, Member of Audit Committee and Member of Governance & Nominating Committee
2012-2012
Former Director

Education*

MBA
Harvard University
BA
Amherst College

Other Affiliations*

Annual Compensation*

Salary$1,490,769
Total Annual Compensation$1,490,769

Stock Options*

Restricted Stock Awards$7,999,917
All Other Compensation$561,121
Exercisable Options352,505
Exercisable Options Value$21,480,177
Unexercisable Options80,995
Unexercisable Options Value$4,691,548
Total Value of Options$26,171,725
Total Number of Options433,500

Total Compensation*

Total Annual Cash Compensation$5,649,890
Total Short Term Compensation$1,490,769
Other Long Term Compensation$8,561,038
Total Calculated Compensation$13,649,807
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMGN:US $122.01 USD +0.90

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Inge G. Thulin Chairman, Chief Executive Officer and President
3M Company
$1.3M
Lars Rebien Sørensen Chief Executive Officer
Novo Nordisk A/S
kr15.2M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMGEN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.